Aridis Pharmaceuticals, Inc. (ARDS)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.2900-0.0600 (-1.79%)
At close: 4:00PM EDT
| Previous close | 3.3500 |
| Open | 3.3200 |
| Bid | 0.0000 x 3000 |
| Ask | 0.0000 x 800 |
| Day's range | 3.1500 - 3.4000 |
| 52-week range | 3.1400 - 8.4700 |
| Volume | 32,687 |
| Avg. volume | 65,360 |
| Market cap | 48.325M |
| Beta (5Y monthly) | 0.14 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.4790 |
| Earnings date | 18 Nov 2021 - 22 Nov 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 18.00 |
- Zacks
Analysts Estimate ARIDIS PHARMACT (ARDS) to Report a Decline in Earnings: What to Look Out for
ARIDIS PHARMACT (ARDS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Aridis' (ARDS) COVID Antibody Combo Neutralizes Delta Variant
Aridis Pharmaceuticals' (ARDS) inhaled COVID-19 dual antibody cocktail treatment, AR-712, binds and neutralizes the Delta variant of the virus. Stock rises in after-hours trading.
- Simply Wall St.
When Can We Expect A Profit From Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS)?
Aridis Pharmaceuticals, Inc. ( NASDAQ:ARDS ) is possibly approaching a major achievement in its business, so we would...
© 2021 Verizon Media. All rights reserved.
